-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Imax, Lowers Price Target to $30

Benzinga·04/24/2025 13:20:41
Listen to the news
Wells Fargo analyst Omar Mejias maintains Imax (NYSE:IMAX) with a Overweight and lowers the price target from $32 to $30.